Recent Advances in siRNA Delivery Systems for Prostate Cancer Therapy-Reference-Cited by-同舟云学术

Recent Advances in siRNA Delivery Systems for Prostate Cancer Therapy

Published:2022-03 Issue:4 Volume:23 Page:579-593
ISSN:1389-2010
Container-title:Current Pharmaceutical Biotechnology
language:en
Short-container-title:CPB

Author:

Aghamiri Shahin¹^ORCID,Raee Pourya²^ORCID,Shahmohamadnejad Shiva³^ORCID,Shabani Sasan⁴^ORCID,Ghorbani Jaber⁵^ORCID,Sameni Marzieh⁶^ORCID,Ebrahimi Mohammad Taha⁶^ORCID

Affiliation:

1. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3. Department of biochemistry, faculty of medicine, Tehran University of medical sciences, Tehran, Iran

4. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Microbiology, school of medicine, Tehran University of Medical Sciences, Tehran, Iran

6. Department of medical biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Abstract: The critical problems of conventional prostate cancer therapeutic strategies like nonspecific toxicity and multi-drug resistance prompted the development and application of countless nanoparticle- based siRNA therapeutics. Unfortunately, siRNA-based therapeutics suffer from the lack of safe and effective delivery systems, immune system stimulation, poor knowledge of nano-bio interactions, and limitations concerning designing, manufacturing, clinical translation, and commercialization. In this review, we provide cutting-edge advances in nanoparticle-mediated siRNA delivery carriers like polymeric systems, lipid systems, specific systems, and rigid nanoparticles for the treatment of prostate cancer. Moreover, co-delivery of conventional chemotherapy drugs with siRNA as a revolutionary robust strategy for prostate cancer combinational therapy is completely covered.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells;Molecular Carcinogenesis;2023-10-03

2. Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view;Reproductive Biology and Endocrinology;2023-09-26

3. Recent advances and future perspectives in the therapeutics of prostate cancer;Experimental Hematology & Oncology;2023-09-22

4. Nanomedicine for urologic cancers: diagnosis and management;Seminars in Cancer Biology;2022-11

5. Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology;Nano Today;2022-08